Science Current Events | Science News | Brightsurf.com
 
corner top left block corner top right

Aspirin does not prevent heart attacks in patients with diabetes

October 17, 2008

The prevention of progression of arterial disease and diabetes: a factorial randomized placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease

Taking regular aspirin and antioxidant supplements does not prevent heart attacks even in high risk groups with diabetes and asymptomatic arterial disease, and aspirin should only be given to patients with established heart disease, stroke or limb arterial disease, according to a study published today on bmj.com.

In light of these findings, and the evidence from six other well controlled trials, the prescribing practice of doctors and international guidelines should be reviewed so that aspirin is only prescribed to patients with established heart and stroke disease, argues the author of an accompanying editorial.

Patients with diabetes are two to five times more likely to suffer from heart disease than the general population and heart disease is a major cause of death in patients with type 1 and 2 diabetes. Although there is considerable evidence showing no protective benefit of aspirin in high risk patients without heart disease, guidelines are inconsistent and aspirin is commonly prescribed for the primary prevention of heart disease in patients with diabetes and with peripheral arterial disease.

But aspirin is one of the top 10 causes of adverse drug events reported to the Commission on Human Medicines. It causes gastrointestinal bleeding and the risk of bleeding increases with age and prolonged use.

Professor Jill Belch and colleagues from Scotland investigated whether aspirin and antioxidants given together or separately can reduce heart attacks and death in patients with diabetes and arterial disease. 1276 patients with diabetes and evidence of artery disease over 40 years of age were randomised to receive either aspirin or placebo, an antioxidant or placebo, aspirin and antioxidant or double placebo, and followed over eight years.

Overall, the researchers found no benefit from either aspirin or antioxidant treatment in the prevention of heart attacks or death. Patients in the aspirin groups had 116 primary events compared with 117 in the placebo group. No significant difference in events was seen between the antioxidant group and the placebo group.

The authors conclude by voicing their concern at the widespread prescribing of aspirin despite the lack of evidence to support its use in the primary prevention of heart attacks and death in people with diabetes and in view of its possible side effects.

These findings show that unlike statins and drugs for reducing hypertension, which have a benefit in all risk groups including those with and without heart disease, only patients with a history of clinical or symptomatic heart disease or stroke disease benefit from taking aspirin, writes Professor William Hiatt in an accompanying editorial.

BMJ-British Medical Journal




Peripheral Arterial Disease

Peripheral Arterial Disease
by Robert Dieter (Author), III, Raymond Dieter (Author), Jr., Raymond Dieter (Author)


A complete guide to understanding and treating peripheral arterial disease A Doody's Core Title! "...especially welcome...One of the many aspects that make this text a wonderful contribution to the literature and deserving of a place in any clinician's library is its comprehensiveness....the diverse backgrounds of the authors contribute to its unique and comprehensive perspective. Peripheral Arterial Disease contains practical information on common disease entities that confront practitioners, as well as insight into the rarer entities that frequently require textbook consultation."--JAMA " It is almost certainly the most comprehensive collection of material devoted solely to noncardiac arterial health and disease ever assembled....This is a good book with something in it for...

  Breast arterial calcification may flag heart disease. (Established Markers Pose Much Higher Risk).: An article from: Family Practice News
by Doug Brunk (Author)


This digital document is an article from Family Practice News, published by International Medical News Group on January 15, 2003. The length of the article is 586 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Breast arterial calcification may flag heart disease. (Established Markers Pose Much Higher Risk).
Author: Doug Brunk
Publication: Family Practice News (Magazine/Journal)
Date: January 15, 2003
Publisher: International Medical News Group
Volume: 33 Issue: 2 Page: 36(1)

Distributed by Thomson...

Peripheral Arterial Disease Handbook

Peripheral Arterial Disease Handbook
by William R. Hiatt (Editor), Judith Regensteiner (Editor), Alan T Hirsch (Editor)


The Peripheral Arterial Disease Handbook presents a unique compendium of evidence-based and expert approaches for the diagnosis and treatment of peripheral arterial diseases written for all practitioners who care for adults with these disorders. This comprehensive, easy-to-use book, presents both epidemiological and pathophysiological data in succinct form, along with a practical clinical review of diagnosis and treatment of the most important areas of peripheral arterial disease care. As such, the Handbook meets the needs of a diverse health care audience, including physicians, nurses, and vascular technologists. Both trainees and practicing clinicians will find this to be an invaluable guide in a rapidly expanding clinical arena.

Peripheral Arterial Disease (Contemporary Cardiology)

Peripheral Arterial Disease (Contemporary Cardiology)
by Jay D. Coffman (Editor), Robert T. Eberhardt (Editor)


Recognized experts comprehensively review the clinical, surgical, radiological, and scientific aspects of atherosclerotic peripheral arterial disease (PAD), including endovascular, gene, and drug therapies. In their far-ranging discussions, the authors examine in depth the risk factors and antiplatelet therapies for PAD patients at high risk for suffering a heart attack and/or and stroke, the question of exercise rehabilitation, the surgical approaches to revascularization, and the preoperative evaluation and perioperative management of the vascular patient. Completing this detailed overview is important information on ameliorating the risk factors for PAD, its pathogenesis and epidemiology, and the physiological and pathophysiological basis of available diagnostic tests.

Pulmonary Arterial Hypertension and Interstitial Lung Diseases: A Clinical Guide

Pulmonary Arterial Hypertension and Interstitial Lung Diseases: A Clinical Guide
by Robert P. Baughman (Editor), Roberto G. Carbone (Editor), Giovanni Bottino (Editor)


Interstitial lung disease (ILD) is a broad category of lung diseases that includes more than 150 disorders characterized by scarring or fibrosis of the lungs. In Pulmonary Arterial Hypertension and Interstitial Lung Disease: A Clinical Guide, renowned experts provide a state-of-the-art overview of the problems seen by physicians in the clinical management of ILDs. Divided into two sections, the first part provides and update on general issues and introduces both interstitial lung disease and associated pulmonary hypertension. A detailed analysis of the pathology of the various interstitial lung diseases is also provided. The second part addresses specific categories of disease. Bronchiolitis, hypersensitivity pneumonitis, and other conditions are covered, and the use of inspiratory and...

Diabetic Foot: Lower Extremity Arterial Disease and Limb Salvage

Diabetic Foot: Lower Extremity Arterial Disease and Limb Salvage
by Anton N. Sidawy (Editor)


Understanding tibio-peroneal occlusive disease and its management is vital in treating patients with peripheral vascular disease. Occlusive disease and the resulting ischemia threaten the viability of the lower limb, particularly in diabetics. Edited by widely-respected vascular surgeon Anton N. Sidawy, this textbook explores all aspects of tibio-peroneal disease, including pathophysiology, diagnosis, treatment, and management of the lower extremity after adequate circulation is restored. It examines risk factors, disease distribution, and general management issues connected with diabetic patients, as well as adjuvant chemotherapy to improve patency of prosthetic bypasses, thrombolytic therapy for failed bypasses, wound healing, and amputations of the foot and leg. ...

Contemporary Diagnosis And Management of Peripheral Arterial Disease

Contemporary Diagnosis And Management of Peripheral Arterial Disease
by William R. Hiatt (Author)


This handbook explains the many aspects of peripheral arterial disease (PAD) to aid the physician with the diagnostic process. the natural history of PAD, its clinical presentation and assessment, and the management of intermittent claudication and critical limb ischemia are the key topics addressed.

Peripheral Arterial Disease (Key Diseases) (Key Diseases)

Peripheral Arterial Disease (Key Diseases) (Key Diseases)
by Emile Mohler (Editor), Michael Jaff (Editor)


Here s a complete resource for general internists on one of the most under-diagnosed conditions in internal medicine, Peripheral Arterial Disease (PAD)! This new book is a concise and practical guide to the diagnosing and treatment methods of PAD. For quick reference, each chapter begins by listing the key questions that will be answered, and ends with a brief summary of what was discussed.

Lower Extremity Arterial Disease (Clinical Hypertension and Vascular Diseases)

Lower Extremity Arterial Disease (Clinical Hypertension and Vascular Diseases)
by Dennis G. Caralis (Editor), George L. Bakris (Editor)


A comprehensive review the state-of-the-art in atherosclerosis of the arteries of the legs and feet. The authors discuss in detail the primary symptom-claudication-an intermittent pain in the leg or foot while walking, its predisposing factors, the current diagnostic methodologies, the impressive advances in the therapeutic armamentarium, and the need to screen for co-existing coronary artery disease. Additional chapters describe cutting-edge noninvasive angiography and vascular flow studies, specific drug therapy for claudication, regression of atherosclerosis therapy, gene therapy, and drug eluting stents for peripheral arterial disease. The authors also examine the epidemiology of LEAD, the effects of smoking and effective smoking cessation programs, its pathogenesis and its...

Peripheral Arterial Disease, An Issue of Cardiology Clinics, 1e (The Clinics: Internal Medicine)

Peripheral Arterial Disease, An Issue of Cardiology Clinics, 1e (The Clinics: Internal Medicine)
by Sanjay Rajagopalan MD (Author)


Peripheral vascular disease is the obstruction of large arteries that are not in the heart or brain.  With the advent of percutaneous treatment techniques, such obstructions are now often being treated by cardiologists.  This issue provides current information on  diagnosis, medical management, and percutaneous procedures for peripheral vascular disease.

corner bottom left corner bottom right
© 2012 BrightSurf.com